Previous Close | 15.03 |
Open | 15.06 |
Bid | 15.10 x 1300 |
Ask | 21.50 x 800 |
Day's Range | 14.54 - 15.37 |
52 Week Range | 7.38 - 28.70 |
Volume | |
Avg. Volume | 755,717 |
Market Cap | 2.01B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 1,503.00 |
EPS (TTM) | 0.01 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.67 |
While not a mind-blowing move, it is good to see that the Cytek Biosciences, Inc. ( NASDAQ:CTKB ) share price has...
FREMONT, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the upcoming 42nd Annual Canaccord Genuity Global Growth Conference in Boston, MA. Cytek’s management is scheduled to participate in a fireside chat on Thursday, August 11th at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors”
FREMONT, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 10th, 2022. The company’s management will webcast a corresponding conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the “Inves